Public Access Records Office
The National Academies
500 5th Street NW
Room KECK 219
Washington, DC 20001
Tel: (202) 334-3543
Project Information

Project Information

Forum on Mental Health and Substance Use Disorders

Project Scope:

The Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine will convene a Forum on Mental and Substance Use Disorders to provide a structured environment and neutral venue to discuss data, policies, practices, and systems that affect the diagnosis and provision of care for mental and substance use disorders, including for substance-related and addictive conditions. Its activities, which will focus on adults (including older adults), will facilitate sustained attention to these conditions throughout the Academies. Forum participants will engage in dialogue on a range of issues, including:

  • innovation to facilitate access to short- and long-term services for mental health and substance use disorders in various care settings;

  • coordination and integration of these services in primary and specialty health care delivery systems;

  • regulatory challenges related to maintaining the confidentiality of behavioral health information and treatment records;

  • standardization of diagnosis and treatment;

  • financing evidence-based care in different settings;

  • policy and systems changes to decriminalize people with mental health and substance use disorders;

  • engagement of patients and families;

  • the use of technology, such as telemedicine and mobile applications, to deliver and support care;

  • standardization of data collection to enable data matching, aggregation, and sharing;

  • the role of recovery, wellness, and peer counseling;

  • benchmarks to assess and improve quality of care;

  • professional education and training; and

  • strategies, technologies, and infrastructure for strengthening the evidence base, care practices, and cultural relevance of diagnosis and interventions.

Forum activities will emphasize potential opportunities for action and may include expert meetings, public workshops, and webinars; summary publications; and targeted communications and community engagement.

Forum members and participants will include federal, state, and local government officials; representatives of consumer and family advocacy groups; service providers; payers; policy analysts; researchers; educators; and representatives of relevant professional associations and foundations

Status: Current

PIN: HMD-HSP-16-02

RSO: Graig, Laurene


Behavioral and Social Sciences
Health and Medicine

Geographic Focus:

Committee Membership

Colleen L. Barry - (Chair)
Colleen Barry is the Fred and Julie Soper Professor and Chair of the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. She has a joint appointment in the Department of Mental Health. Professor Barry's research focuses on how health and social policies can affect a range of outcomes for individuals with mental illness and substance use disorders, including access to medical care and social services, care quality, health care spending, financial protection and mortality. She is involved in numerous research studies examining the implications of health insurance expansions and health care delivery system reform efforts on the treatment of mental illness and substance use disorders. She also conducts empirical research to understand how communication strategies influence public attitudes about opioid addiction, mental illness, gun policy, and obesity and food policy. One focus of this work is to identify evidence-based approaches to reducing stigma. She has authored over 160 peer-reviewed articles on these topics. Dr. Barry is founding co-Director (with Elizabeth Stuart) of the Johns Hopkins Center for Mental Health and Addiction Policy Research and is a core faculty member in the Johns Hopkins Center for Gun Policy and Research. Professor Barry received her Ph.D. in health policy from Harvard University and her masters degree in public policy from the John F. Kennedy School of Government at Harvard.
Howard H. Goldman - (Co-Chair)
Howard H. Goldman, M.D., Ph.D., is a professor of psychiatry at the University of Maryland School of Medicine. His expertise is in evaluating mental health services and financing programs and policies. Dr. Goldman’s recent research has focused on evaluating employment demonstrations for people with severe mental disorders who are connected to the disability programs of the Social Security Administration (SSA). He has also been involved in various studies related to early intervention services for individuals experiencing a first episode of psychosis. In the past he served as principal investigator of the study team conducting the Evaluation of the Implementation and Impact of Mental Health and Substance Abuse Parity in the Federal Employees Health Benefits program, sponsored by the government. Dr. Goldman served as the senior scientific editor of the Surgeon General's Report on Mental Health from 1997 to 1999, for which he was awarded the Surgeon General’s Medallion. During 2002 and 2003, Dr. Goldman was a consultant to the President’s New Freedom Commission on Mental Health. From 2004 to 2016 he served as editor of Psychiatric Services, a mental health services research and policy journal published monthly by the American Psychiatric Association. He has served on the editorial boards of several other journals, including Health Affairs, the American Journal of Psychiatry and the Journal of Mental Health Policy and Economics. He is a member of the National Academy of Social Insurance, having served on its disability policy panel. Dr Goldman is a member of the NAM, who currently chairs a Standing Committee providing advice to SSA on its disability programs. He has also served as a member or consultant on numerous NASEM consensus committees related to disability policy. Dr. Goldman received joint M.D.-M.P.H. degrees from Harvard University and a Ph.D. in social policy research from the Heller School at Brandeis University
Margarita Alegria - (Member-at-Large)
Margarita Alegría is the Chief of the Disparities Research Unit at the Massachusetts General Hospital and a Professor in the Departments of Medicine and Psychiatry at Harvard Medical School. From 2002-2015 she was the Director of the Center for Multicultural Mental Health Research at Cambridge Health Alliance, and was previously the Director of the Center for Evaluation and Sociomedical Research at the University of Puerto Rico. Dr. Alegría has been a Professor in the Department of Psychiatry at Harvard Medical School since 2004.

Throughout her career, she has remained dedicated to generating knowledge that can be used to increase equity in health outcomes and healthcare services for disadvantaged and minority populations. Dr. Alegría’s research has integrated three methods: a multidisciplinary and multisectorial approach to research; a multi-level framework which gives necessary consideration to environmental and social context, the individual and family system; and a strong focus on which aspects of culture and context need to be addressed to improve health, as well as service delivery for diverse populations. Dr. Alegría sis currently the Principal Investigator (PI) of three National Institutes of Health (NIH)-funded research studies: Building Community Capacity for Disability Prevention in Minority Elders; Mechanisms Underlying Racial/ Ethnic Disparities in Mental Disorders; and The Impact of Medicaid Plans on Access to and Quality of Substance Use Disorder (SUD) Treatment. She is also the PI of a grant funded by the William T. Grant Foundation, entitled Using the Experience of Majority and Minority Status Through Photovoice.

Dr. Alegría has published over 200 papers, editorials, intervention training manuals, and several book chapters, on topics such as improvement of health care services delivery for diverse racial and ethnic populations, conceptual and methodological issues with multicultural populations, and ways to bring the community’s perspective into the design and implementation of health services. In October 2011, she was elected as a member of the National Academy of Medicine in acknowledgement of her scientific contributions to her field. She has also been a recipient of notable awards, such as the Mental Health Section Award by the American Public Health Association (2003), the Health Disparities Innovation Award by the National Institutes of Minority Health (2008), and the Simone Bolivar Award by the American Psychiatry Association (2009). Most recently, Dr. Alegria was the recipient of the 2018 Jonathan Mann Award by the New Mexico Public Health Association in recognition of her lifetime commitment to public health and social justice issues.

Dr. Alegría obtained her B.A. in Psychology from Georgetown University in 1978 and her Ph.D. from Temple University in 1989.
Richard G. Frank - (Member-at-Large)
Richard G. Frank is the Margaret T. Morris Professor of Health Economics. His research is focused on the economics of mental health and substance abuse care, long term care financing policy, health care competition and implementation of health reform and disability policy. He served as the deputy assistant secretary for planning and evaluation at the Department of Health and Human Services (DHHS), directing the office of Disability, Aging and Long-Term Care Policy from 2009-2011. From 2014-2016, he served as the DHHS assistant secretary for planning and evaluation. Dr. Frank served as an editor for the Journal of Health Economics for nine years. He was awarded the Carl A. Taube Award from the American Public Health Association and the John Eisenberg Mentorship Award from the National Research Service Awards. He is a member of the National Academy of Medicine. He received the AcademyHealth Distinguished Investigator Award in June 2018. He is co-author with Sherry Glied of the book Better but Not Well (Johns Hopkins Press). Dr. Frank received his BA in economics from Bard University and his PhD in economics from Boston University.
Ruth Shim - (Member-at-Large)
Ruth Shim is holder of the Luke & Grace Kim Professorship in Cultural Psychiatry in the Department of Psychiatry and Behavioral Sciences at the University of California, Davis School of Medicine. She is an Associate Professor of Clinical Psychiatry, Director of Cultural Psychiatry, and Chair of the Vice Chancellor’s Advisory Committee on Faculty Excellence in Diversity at UC Davis Health.

Dr. Shim received an MPH in health policy from Rollins School of Public Health at Emory University and an MD from Emory University School of Medicine. She is a member of the Board of Trustees of the Robert Wood Johnson Foundation and the American Association of Community Psychiatrists. She serves on the Editorial Boards of Psychiatric Services, Community Mental Health Journal, and American Psychiatric Publishing, and is co-editor of the book, The Social Determinants of Mental Health. She is a 2018-2019 Fellow of the Executive Leadership in Academic Medicine (ELAM) Program.

Dr. Shim’s research focuses on mental health disparities and inequities, and she provides clinical psychiatric care in the UC Davis Early Diagnosis and Preventative Treatment (EDAPT) Clinic.
Michael Weaver - (Member-at-Large)
Mike Weaver is the Executive Director of the International Association of Peer Supporters, advocating for the inclusion of peer support in healthcare and other community systems. He has advocated for those living with difficult challenges for many years after reinventing his life after disruption by mental health challenges and incarceration. Mike has served in clinical and peer roles, is a peer support facilitator, Advanced WRAP facilitator and author of “Helping Others Heal”, a peer support manual.
Mike served for six years on the National Alliance on Mental Illness Board of Directors and three years as Policy Chair. He has trained law enforcement officers in Crisis Intervention Team training for a decade and is regarded as a subject matter expert on criminal justice issues. He is a member of the United States team of the International Initiative on Mental Health Leadership. He speaks on many topics including peer support, recovery, fully informed care, self-determination and self-management, re-entry from incarceration, seclusions and restraints and shared decision making. He has an optimistic view toward people living with what are regarded as serious mental illnesses and addictions. As Napoleon Bonaparte once said, “A leader is a dealer in hope.”
Dara Blachman-Demner - (Ex Officio Member)
Dara Blachman-Demner is a Health Scientist Administrator in the Office of Behavioral and Social Sciences Research (OBSSR) at the National Institutes of Health. In that role, she is primarily focused on efforts to facilitate the adoption of behavioral and social science findings into health research and practice. A licensed psychologist, Dr. Blachman-Demner received her BA from Duke University and her Ph.D. in clinical/community psychology from the University of California, Berkeley. She completed her clinical internship at the Institute for Juvenile Research at the University of Illinois, Chicago and a postdoctoral fellowship at the Family Institute/School of Education and Social Policy at Northwestern University. Prior to joining OBSSR in January 2017, she served as a Social Science Analyst at the National Institute of Justice (NIJ) for six years where she initiated and oversaw portfolios related to the impact of youth violence and victimization experiences on health outcomes.

Prior to NIH, Dr. Blachman-Demner served as the Coordinator of the Federal Interagency Forum on Child and Family Statistics, a collaboration of 22 Federal agencies that produce or use data related to children and families. Dr. Blachman-Demner began her Federal career as a Society for Research in Child Development/AAAS policy fellow at OBSSR from 2006-2008. Dr. Blachman-Demner’s research interests lie in the area of implementation science and related efforts designed to facilitate the translation, adoption and scale up of evidence based health interventions, practices and knowledge into clinical, community and public health settings. Within this arena, she has interest in working to coordinate across the health, justice, education, and social service sectors to ensure that health interventions reach individuals in a variety of settings as well as in community-engaged research to facilitate adoption and implementation. In addition, she remains focused on advancing the science of prevention and treatment of mental disorders and promotion of positive health outcomes among children and youth with a particular emphasis on youth from minority and traditionally underserved communities.
Carlos Blanco - (Ex Officio Member)
Carlos Blanco, PhD is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autónoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.
Martin D. Brown - (Ex Officio Member)
Marty Brown serves as President of PYA, an advisory firm for the healthcare and business community. During his tenure, Marty has helped the firm to national recognition that includes INSIDE Public Accounting Top 100 Firm, Modern Healthcare Top 15 Healthcare Consulting Firm, and INSIDE Public Accounting Third Highest Percentage Female Ownership Among Top 100 Firms. PYA also was featured in Accounting Today’s “Inside the Top 100—In-Depth Looks at Four of the Most Successful Firms in the Country.” Marty’s leadership experience spans three decades, many industries, and organizations. Prior to joining PYA, Marty served as a senior manager at KPMG. In addition to his current role as President of PYA, Marty also leads the Firm as Managing Principal of Consulting Services, a position he has filled since 2006. His deep and broad insight into healthcare, valuation, financial analysis and oversight, and strategic planning is the basis for his ability to define, seize, and best leverage market opportunities for PYA’s client partners. He also is a champion for excellence, hiring and promoting professionals of highest character. Marty is a certified public accountant.
Jeffrey Buck - (Ex Officio Member)
Jeffrey Buck is the Program Lead for the Inpatient Psychiatric Facility (IPF) Quality Reporting Program and the Senior Advisor for Behavioral Health in the Center for Clinical Standards and Quality (CCSQ) at the Centers for Medicare & Medicaid Services (CMS). He serves as the subject matter expert for the QIO Program’s behavioral health work. Previously, he served as a senior advisor with the agency’s Center for Strategic Planning. Before coming to CMS, Dr. Buck held senior positions in the Substance Abuse and Mental Health Services Administration (SAMHSA). There, he directed many of SAMHSA’s analytic studies of behavioral health services and financing. Dr. Buck’s publications have addressed behavioral health issues in the financing and utilization of services, insurance coverage and parity, Medicaid, health care reform and administrative data systems.
Michael Colston - (Ex Officio Member)
Navy Capt. (Dr.) Mike Colston is the DCoE director. He is responsible for the work of approximately 600 employees at DCoE headquarters and centers who work to improve the lives of our nation’s service members, families and veterans by advancing excellence in the prevention and care of psychological health conditions and traumatic brain injury.

Colston joined the Navy as a line officer, serving as a nuclear engineer and surface warfare officer aboard USS Carl Vinson (CVN-70), deploying twice to the Arabian Sea and completing a Pacific Rim Exercise. Transitioning to the Medical Corps, he earned a medical degree from the Uniformed Services University of the Health Sciences; trained as a resident in psychiatry at Walter Reed Army Medical Center, Bethesda, Maryland; and completed a fellowship in child and adolescent psychiatry at Northwestern University in Chicago. Colston holds a Bachelor of Science degree in Industrial and Management Engineering from Rensselaer Polytechnic Institute and a master’s degree in Marine Affairs from the University of Rhode Island.

In previous medical corps assignments, Colston served as Chief of the Mental Health Department at Naval Hospital Great Lakes, overseeing a large-scale clinical integration that led to merged VA-DoD services at the Lovell Federal Health Care Center. During deployment in support of Operation Enduring Freedom, he led a combat and operational stress team that supported a catchment of 10,000 service members. As director of the Mental Health Program in the Office of the Assistant Secretary of Defense for Health Affairs, Colston managed a mental health board project that reviewed over 200,000 cases involving posttraumatic stress disorder (PTSD) and depression diagnoses, led a mental health team in the independent investigation of the 2013 Washington Navy Yard tragedy, and co-chaired the Defense Department Addictive Substances Misuse Advisory Committee, helping address a nationwide scourge of opiate addiction on several fronts.

Colston is an experienced leader and speaker representing the Defense Department in testimony to Congress and presidential executive offices including the Office of National Drug Control Policy, the Domestic Policy Council, and the National Security Council. Colston served on research advisory boards for the Congressionally-directed Medical Research Program, the Military Suicide Research Consortium and the National Institutes of Health National Advisory Council on Neurological Disorders and Stroke. As an author, Colston wrote a chapter on the forensic aspects of PTSD in the “Textbook of Military Medicine” series, and is published in peer-reviewed journals on topics including uncertainties in diagnosis and treatment of mental illnesses and bioethical considerations related to research in psychological health; traumatic brain injury; and suicide.

Colston is credentialed at Fort Belvoir Community Hospital, Virginia, is board certified in child and adolescent psychiatry, and has practiced in inpatient, outpatient and stepdown addiction settings. His military awards and decorations include the Defense Superior Service Medal, the Office of the Secretary of Defense Badge, Surface Warfare and Officer-in-Charge Afloat devices, and campaign medals and ribbons spanning four overseas operations.

Karen Drexler - (Ex Officio Member)
Karen Drexler is board certified in Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology. She serves as National Mental Health Program Director for Substance Use Disorders in the Office of Mental Health and Suicide Prevention in VA Central Office.

Dr. Drexler graduated from Duke University School of Medicine and completed her psychiatry residency at Wilford Hall U.S. Air Force Medical Center in San Antonio, Texas. She served 4 years as a psychiatrist and Medical Director of the Alcohol Rehabilitation Center at Wright-Patterson Air Force Base and on the faculty at Wright State University School of Medicine in Dayton, Ohio. She currently serves as an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. Her research interests include health services research in addiction prevention and treatment.

Dr. Drexler currently serves as a member of the Board of Directors of the American Academy of Addiction Psychiatry, and as a member of the Executive Committee of the Board of Directors of CADCA (the Community Anti-Drug Coalitions of America). She continues to actively practice addiction psychiatry at the Atlanta VA Medical Center.
Thaddeus Flood - (Ex Officio Member)
Thaddeus (Thad) Flood is the Director of Reimbursement and Policy at Otsuka where he provides strategic guidance on key government and policy issues. Prior to joining Otsuka, Thaddeus worked within a federally funded research and development center supporting the creation and implementation of the Merit-based Incentive Payment System mandated by Congress under MACRA and supported development for several other Medicare payment and quality programs. He has additional experience advising medical imaging and radiation therapy manufacturers on FDA issues and worked at HHS/ONC as a project officer for federal health IT programs. Thaddeus has a BA from Fordham University in International Political Economy, and a Juris Doctor from American University.
Robert Forman - (Ex Officio Member)
Robert Forman joined Alkermes in 2005 as a clinical scientist and since that time has held several positions at the company. In his current role, Dr. Forman is responsible for review, analysis, and development of addiction and mental health policy. In addition to his position at Alkermes, he serves on the faculty of McLean Hospital, a Harvard Medical School affiliate; and previously served on the faculty of Center for Studies of Addiction of the University Pennsylvania School of Medicine; Treatment Research Institute; and Villanova University. Additionally, Dr. Forman opened and managed more than 20 addiction treatment programs in a wide range of clinical settings. His NIDA-funded research focused on measuring and improving treatment quality in addiction treatment settings; therapeutic alliance; availability of controlled substances without prescription over the internet; and clinical trials of psychosocial interventions and addiction treatment medications. Dr. Forman has published more than 60 scientific and professional articles, chapters and books. He has served as a consultant to numerous national organizations and has chaired two SAMHSA Treatment Improvement Protocols on the outpatient treatment of substance use disorders. Dr. Forman received his doctorate in Child Clinical Psychology & Counseling from Bryn Mawr College.
Michael C. Freed - (Ex Officio Member)
Michael Freed is the Chief of the Services Research and Clinical Epidemiology Branch at the National Institute of Mental Health (NIMH). Under his guidance, the branch helps set institute research priorities, develops funding initiatives, and administers a public health–oriented research portfolio to increase access, continuity, quality, equity, efficiency, and value of mental health services to those in need. The branch also manages the dissemination and implementation research portfolio for the institute. Dr. Freed joined NIMH from the Department of Defense, where, as the research director of an interdisciplinary team of researchers, clinicians, and support staff, he worked to transform behavioral health care across the military health system, to include developing and testing models of care integration. He served in principal and co-investigator roles on several key epidemiological and health services research studies, to include clinical trials. He also assisted with research priority setting and helped design a system to expedite the translation of findings from research to practice. Dr. Freed is a licensed and practicing psychologist, holds academic appointments in the Department of Psychiatry and the Center for the Study of Traumatic Stress at the Uniformed Services University of the Health Sciences, and has been recognized by both the Department of Defense and NIMH for significant achievement.
Chelsey Goddard - (Ex Officio Member)
Chelsey Goddard is Vice President of Education Development Center’s Behavioral Health Programs and, until recently, was director of SAMHSA’s Center for the Application of Prevention Technologies (CAPT) at EDC. She has 20 years of experience transforming prevention science into training and technical assistance (T/TA) services and products for diverse audiences. Her ability to translate public health research into effective processes, tools, and products for states and communities has advanced the substance abuse prevention field. At EDC, Goddard’s strategic direction of the CAPT’s programmatic activities, including T/TA to facilitate the selection, implementation, and evaluation of evidence-based, culturally appropriate, sustainable prevention activities, enabled the CAPT to deliver workforce training to 14,233 practitioners, and capacity-building services to more than 1,710 people across the country last year. A certified prevention specialist, Goddard holds an MPH from the University of Michigan. She was a Fellow in the Leadership Education in Neurodevelopmental and Related Disabilities (LEND) program at the Institute for Community Inclusion at Boston Children's Hospital.
Althea M. Grant-Lenzy - (Ex Officio Member)
Captain Althea Grant-Lenzy, PhD, currently serves as the Senior Advisor for Science for Deputy Director for Non-Infectious Diseases (DDNID) at the Centers for Disease Control and Prevention. She is responsible for advising the Deputy Director on cross-cutting science activities and opportunities in the area of non-infectious diseases (chronic diseases, birth defects and developmental disabilities, injury, and environmental health). The primary focus of CAPT Grant-Lenzy’s work currently is coordinating science across behavioral health areas including mental health, marijuana and alcohol.

CAPT Grant-Lenzy joined CDC in 2002 as an Epidemic Intelligence Service Officer assigned to the Women’s Health ad Fertility Branch in the Division of Reproductive Health. From 2004 through 2007, she served as Epidemiologist in the Maternal and Infant Branch in the Division of Reproductive Health. In 2007, she became the Team Leader of the Epidemiology and Surveillance Team in the Division of Blood Disorders in the National Center on Birth Defects and Developmental Disabilities (NCBDDD) at CDC. In 2010, she was promoted to the position of Chief of the Epidemiology and Surveillance Branch in the same division. She also previously served as Acting Director for the Division of Blood Disorders. CAPT Grant-Lenzy is a recognized national leader championing public health programs for blood disorders particularly hemoglobinopathies such as sickle cell disease and thalassemia. She served as CDC’s Project Director for the RuSH program, the first population-based public health surveillance system for sickle cell disease and thalassemia conducted in collaboration with NIH/NHLBI. In 2009, she received a Commendation Medal from the US Public Health Service in recognition for developing programs to improve the health of individuals affected by sickle cell disease. In 2009 and 2011, CAPT. Grant-Lenzy served as U.S. Representative on behalf of the State Department for the 1st and 3rd UN World Sickle Cell Days. She has also served as Temporary Advisor to the World Health Organization and UNICEF.

CAPT Grant-Lenzy has many presentations at national conferences/meetings and over 50 publications in peer reviewed journals. She received her PhD in Biochemistry and Molecular Biology from Emory University and is a certified Six Sigma Black Belt.

Pamela Greenberg - (Ex Officio Member)
Pamela Greenberg is the President and CEO of the Association for Behavioral Health and Wellness (ABHW); she joined the organization in 1998 and since that time has become a nationally recognized leader on managed behavioral health care policy. In her role, she works on a variety of issues that are important to health plans and will increase quality and access to behavioral health care.

ABHW is the leading association working to raise awareness, reduce stigma, and advance federal policy to improve mental health and addiction care. ABHW represents major national and regional health plans who care for more than 200 million people.

Pamela serves as a liaison to the National Committee for Quality Assurance Standards Committee. In 2017, Ms. Greenberg joined InnovaTel Telepsychiatry’s Strategic Advisory Board. She was the Chair of the Coalition for Fairness in Mental Illness Coverage, one of the leading coalitions that helped develop, advocate for, and get the Wellstone-Domenici Mental Health Parity and Addiction Equity Act of 2008 signed in to law. Additionally, Pamela served as President of The College for Behavioral Health Leadership.

Prior to joining ABHW Pamela was the Deputy Director of Federal Affairs for America’s Health Insurance Plans (AHIP). Before joining AHIP Ms. Greenberg was a Legislative Assistant at Capitol Associates, a healthcare consulting firm in Washington, D.C. Pamela has a B.A. from Mount Holyoke College and a Master’s in Public Policy from Georgetown University.
Larke Nahme Huang - (Ex Officio Member)
Larke Huang is a licensed clinical-community psychologist at the Substance Abuse and Mental Health Services Administration (SAMHSA) in the U.S. Department of Health and Human Services. She provides leadership on national policy for mental health and substance use issues for children and adolescents, is Director of SAMHSA’s Office of Behavioral Health Equity which was legislated by the Patient Protection and Affordable Care Act, and oversees SAMHSA’s trauma and criminal/juvenile justice portfolio. For the past 30 years, Dr. Huang has worked at the interface of practice, research and policy. She received her doctorate from Yale University.

Dr. Huang has been a community mental health practitioner, a faculty member at the University of California, Berkeley and Georgetown University, and a research director at the American Institutes for Research. She has worked with states and communities to build systems of care and model policies for children and youth with serious emotional and behavioral disorders; diversion programs for individuals with SMI and SUD at the nexus of behavioral health and criminal justice; and trauma-informed approaches in multiple health and social service settings. She has developed programs for underserved, culturally and linguistically diverse populations, evaluated community-based programs, and authored books and articles on behavioral health.

Dr. Huang served as an appointed Commissioner on the President’s New Freedom Commission on Mental Health, is an ongoing member of the Carter Center Mental Health Board, and serves on multiple APA committees and boards.

Kristen Kroeger - (Ex Officio Member)
Kristin Kroeger currently serves as the Chief of Policy, Programs, & Partnerships at the American Psychiatric Association. Ms. Kroeger primary role at APA is to oversee coordination and implementation of all policy priorities and programs, as well as build relationships with all allied and external partners. It comes at an important time when we need to push Congress to implement mental health parity, become leaders in developing quality measures for our field and encourage our practitioners to embrace new models of care. Ms. Kroeger has worked in the mental health policy and advocacy arena for over 25 years and comes to us from our allied organization, the American Academy of Child and Adolescent Psychiatry (AACAP). For 18 years she served as AACAP’s Deputy Executive Director and Director of Government Affairs and Clinical Practice. She wore many hats, including setting internal and external policy with leadership and members, advocating to members of Congress and federal agencies, as well as working with leadership and staff to ensure they built stronger relationships with allied pediatric medical organizations and consumer organizations. Prior to working at AACAP, Ms. Kroeger worked for the National Alliance on Mental Illness.
Husseini K. Manji - (Ex Officio Member)
Husseini Manji is Global Therapeutic Head for Neuroscience at Janssen Research & Development, LLC, one of the Johnson & Johnson pharmaceutical companies. He is also Visiting Professor at Duke University. Dr. Manji was previously Chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institutes of Health (NIH) and Director of the NIH Mood and Anxiety Disorders Program, the largest program of its kind in the world.

The major focus of Dr. Manji’s research is the investigation of disease- and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in neuropsychiatric disorders. His work has helped to conceptualize these illnesses as genetically-influenced disorders of synaptic and neural plasticity and has led to the investigation of novel therapeutics for refractory patients. Dr. Manji has also been actively involved in developing biomarkers to help refine these multifactoral diseases.

Dr. Manji has received a number of prestigious awards, including the NIMH Director's Career Award for Significant Scientific Achievement, the A. E. Bennett Award for Neuropsychiatric Research, the Ziskind-Somerfeld Award for Neuropsychiatric Research, the NARSAD Mood Disorders Prize, the Mogens Schou Distinguished Research Award, the ACNP’s Joel Elkes Award for Distinguished Research, the DBSA Klerman Senior Distinguished Researcher Award, the Briggs Pharmacology Lectureship Award, the American Federation for Aging Research Award of Distinction, the Caring Kind Alzheimer’s Disease Leadership Award, and the Global Health & the Arts Award of Recognition. He has received PhRMA’s Research & Hope Award for Excellence in Biopharmaceutical Research, and has also been recognized as one of 14 inaugural “Health Heroes” by Oprah magazine.

Dr. Manji has been inducted into the National Academy of Medicine (formerly IOM), the World Economic Forum (WEF) Global Future Councils, and has held numerous leadership positions within the NAM, the FNIH Biomarkers Consortium Executive Committee, the ACNP, and the Society of Biological Psychiatry.

Throughout his career, Dr. Manji has also been committed to undertakings related to medical and neuroscience education and has worked with the National Board of Medical Examiners (NMBE), the Howard Hughes Medical Institute Research Scholars Program, and numerous national curriculum committees. He founded and co-directed the NIH Foundation for the Advanced Education in the Sciences Graduate Course in the Neurobiology of Neuropsychiatric Illness, and has received several teaching and mentoring awards. He has also served as Editor, and on editorial boards of numerous scientific journals.

Dr. Manji has published extensively on the molecular and cellular neurobiology of severe neuropsychiatric disorders and development of novel therapeutics, with over 300 publications in peer-reviewed journals, including Science, Science Translational Medicine, Nature Neuroscience, Nature Reviews Neuroscience, Nature Reviews Drug Discovery, NEJM, J Clinical Investigation, PNAS, J Neuroscience, JAMA Psychiatry, Molecular Psychiatry.

R. Kathryn McHugh - (Ex Officio Member)
R. Kathryn McHugh received her B.A. from Harvard College and her Ph.D. in from Boston University. She is currently the Director of the Stress, Anxiety and Substance Use Laboratory at McLean Hospital and an Assistant Professor at Harvard Medical School. Dr. McHugh's research focuses on the nature and treatment of anxiety and substance use disorders. Her work is currently funded by grants from the National Institute on Drug Abuse, including a 5-year grant to develop and test a novel cognitive-behavioral therapy for co-occurring opioid use disorder and anxiety disorders. She has published more than 100 manuscripts and book chapters as well as an edited book published by Oxford University Press on the dissemination and implementation of treatment for psychological disorders. Dr. McHugh is a recipient of a number of awards, including the David Shakow Early Career Award for Distinguished Scientific Contribution to Clinical Psychology and the Theodore Blau Early Career Award for Outstanding Contribution to Professional Clinical Psychology. She is an Associate Editor of the journals Behavior Therapy and Cognitive Therapy and Research and recently was the Co-Chair of the American Psychological Association Taskforce on Clinical Responses to the Opioid Crisis . Dr. McHugh is also a practicing clinical psychologist, specializing in cognitive-behavioral therapy for the treatment of anxiety, depressive, and substance use disorders.
Tyler Norris - (Ex Officio Member)
Tyler Norris is chief executive, Well Being Trust, an impact philanthropy with a mission to advance the mental, social, and spiritual health of the nation. Over the past three decades, Tyler has shaped health and development initiatives in hundreds of communities in the U.S. and around the world. He has an extensive background as a social entrepreneur, and trusted advisor to philanthropies, health systems, government agencies, and collaborative partnerships working to improve the health of people and places.

Prior to becoming the first chief executive of Well Being Trust, Tyler served as vice president, Total Health at Kaiser Permanente, where he led “anchor institution" work, applying all organizational assets to impact the economic, social and environmental determinants of health. He previously served as the founding president and CEO of Community Initiatives, and as founding board chair of IP3, the social enterprise that gave birth to the Community Commons, a GIS data mapping and stories platform. In addition to serving on multiple boards and councils ranging from Naropa University to Enterprise Community Partners, previously, he helped open the Abraham Path through the heart of the Middle East, and led the Kuhiston Foundation that helped establish the national park system in Tajikistan. He is a graduate of Harvard Business School’s Executive Program, earned a Master of Divinity degree from Naropa University, and has a bachelor’s degree in World Political Economy from Colorado College.

Kathy Pham - (Ex Officio Member)
Kathy Pham is the Director of Policy and Professional Affairs at the American College of Clinical Pharmacy (ACCP), a professional and scientific society that provides leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice, research, and education. Dr. Pham came to ACCP from the Pew Charitable Trusts, where she served as Senior Officer of the Drug Safety Project. Her previous clinical experience has been in pediatric pharmacy practice, with the majority of that time spent as the NICU clinical specialist and pharmacy residency director at Children's National Medical Center in Washington, D.C. She is also a board-certified pediatric pharmacotherapy specialist.

Dr. Pham earned her Doctor of Pharmacy degree from Rutgers, the State University of New Jersey. After completing her pharmacy residency at the University of Illinois at Chicago, she practiced as a pediatric clinical pharmacist and held faculty appointments at various schools of pharmacy including Long Island University, Rutgers, Creighton University, University of Maryland, and Virginia Commonwealth University.

Dr. Pham leads ACCP's engagement, collaboration, and communication with medical, pharmacy, other health professional societies, health quality organizations, and payers/purchasers to promote and help achieve medication optimization for individual patients and populations. She participates as the ACCP representative in working groups and task forces of health policy development and research enterprises at the national level that address issues of interprofessional practice, research, and education.
Deidra Roach - (Ex Officio Member)
Dr. Roach has more than 30 years of experience in the field of addiction treatment. She currently serves as a medical project officer for the National Institute on Alcohol Abuse and Alcoholism where, among other responsibilities, she manages research portfolios addressing the treatment of co-occurring mental health and alcohol use disorder and alcohol-related HIV/AIDS among women. She also serves on the Interagency Coordinating Committee on Fetal Alcohol Spectrum Disorders (ICCFASD), the NIH Coordinating Committee for Research on Women’s Health, and the Extramural Advisory Work Group, Subcommittee on Inclusion Governance, a trans-NIH committee to advise the Office of the Director/NIH on matters related to ensuring diversity in research participation. Dr. Roach co-chairs the Interagency Work Group on Drinking and Drug Use in Women and Girls, a trans-DHHS committee which promotes collaborative research and other activities focused on the prevention and treatment of substance use and co-occurring mental health disorders among women and girls.
Martin Rosenzeig - (Ex Officio Member)
Dr. Rosenzweig is a the chief medical officer of Optum Behavioral Health and has been with the organization for almost 20 years. Dr. Rosenzweig is board-certified in psychiatry and a clinical associate in the Department of Psychiatry at the University of Pennsylvania. In addition to his work with Optum, he maintains a role in active clinical practice focused on the treatment of individuals with mood disorders and other psychiatric disorders. He is a Graduate of the University of the Witwatersrand Medical School in Johannesburg, South Africa and completed his residency and psychiatric residency at Pennsylvania hospital and his fellowship in psychopharmacology at the University of Pennsylvania.
Alexander Ross - (Ex Officio Member)
Alexander Ross is senior advisor on behavioral health in the Office of Planning, Analysis and Evaluation, at the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Service. Alex supports HRSA Bureaus and Offices fostering the integration of behavioral health and primary care. Dr. Ross’ work has included an emphasis on financing issues regarding behavioral health/primary care services and assuring that an appropriately trained health care workforce is available to meet the Nation’s needs. In addition to his current work, Dr. Ross has held positions at HRSA in the Office of Planning and Evaluation, the Bureau of HIV/AIDS, and the Office of Public Health Practice. Alex has a Doctor of Science Degree in Health Policy from The Johns Hopkins University Bloomberg School of Hygiene and Public Health.
Darla Spence Coffey - (Ex Officio Member)
Darla Spence Coffey is the President and Chief Executive Officer of the Council on Social Work Education (CSWE). CSWE is the national association for social work education, representing over 800 accredited undergraduate and graduate programs of professional social work. Through its programs and initiatives, CSWE promotes emerging technologies, interprofessional education, and innovative models, pedagogies, and practices to advance social work education. As the voice of social work education, CSWE works to strengthen the position of social work within higher education, the national political environment, and in the perceptions of the general public. Coffey received her BSW from Eastern College, her MSW from the University of Pennsylvania, and her PhD from Bryn Mawr College Graduate School of Social Work and Social Research. She has an extensive background in social work practice in the areas of mental health, substance abuse, and domestic violence. More recently, Coffey has been advancing the causes of provider well-being and leadership in presentations and writings. Coffey is a Distinguished Fellow in the National Academies of Practice and is the 2017 recipient of the Advocate for Human Rights Award by the Mandel School of Applied Social Sciences at Case Western Reserve University.
Matthew Tierney - (Ex Officio Member)
Mattew Tierney represents the American Psychiatric Nurses Association (APNA), the largest professional membership organization committed to the specialty practice of psychiatric-mental health nursing and wellness promotion, with over 11,000 nurse members from around the world. Matt is Associate Clinical Faculty at the University of California San Francisco (UCSF) School of Nursing, and is the Clinical Director of Substance Use Treatment and Education at the UCSF Office of Population Health. As a Nurse Practitioner in Adult Primary Care (ANP) and Psychiatric/Mental Health (PMHNP), he is a clinician and educator whose work is focused on improving essential substance use treatment delivery locally, regionally, and nationally.

Matt’s clinical work focuses on developing and implementing innovative care models for addiction treatment, including the first clinic in the nation dedicated solely to the initiation of buprenorphine treatment of opioid use disorder. As an educator, his work focuses on provider knowledge and empowerment. Since 2008, he has taught the federally-mandated educational content required for the DEA waiver to prescribe buprenorphine. He was one of the first nurses to be a national mentor in SAMHSA’s Provider’s Clinical Support System ( He has contributed to the development of national and international nursing education and professional competencies in mental health and substance use. At APNA, Matt was the inaugural chair of the Addictions Council from 2013 to 2018, where at the request of the White House ONDCP he led the development of free on-line education to help nurses nationwide address the opioid epidemic. These educational products have been accessed by over 25,000 nurses nationwide.

Matt Received an MS degree from the UCSF School of Nursing, and in 2018 was named a Fellow of the American Academy of Nursing (FAAN), where he is a member of the Expert Panel on Psychiatric-Mental Health and Substance Use.

Michael Toedt - (Ex Officio Member)
Rear Adm. Michael Toedt, M.D., serves as the Chief Medical Officer of the Indian Health Service. The IHS, an agency within the Department of Health and Human Services, is the principal federal health care provider for American Indians and Alaska Natives.

As the CMO, Rear Adm. Toedt is IHS’s lead expert on medical and public health topics, giving technical advice and guidance to the IHS Office of the Director and IHS staff throughout the country on American Indian and Alaska Native health care policies and issues. He provides national leadership for the clinical and community-based health programs of the agency, and serves as the primary liaison and advocate for IHS health professionals. Rear Adm. Toedt previously served as the Chief Medical Officer for the IHS Nashville Area, where he provided leadership and guidance for the Nashville Area medical services delivery, partnering with 29 Tribes or tribal organizations in 14 states. In 2014-2015, Rear Adm. Toedt served as the Acting Chief Medical Information Officer for the IHS, leading clinical informatics for the development, deployment, and improvement of the HIS Resource and Patient Management System Electronic Health Record. Rear Adm. Toedt is responsible for overall patient care policy and program development, implementation, monitoring and evaluation. He provides consultation and technical assistance for evaluating, designing, and implementing health care delivery systems and coordinates with staff regarding health services, clinical guidelines, and planning activities. Rear Adm. Toedt serves as an advocate for quality health care services for Indian people. Rear Adm. Toedt earned a Doctor of Medicine degree from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, and a Bachelor of Science in applied physics from the Georgia Institute of Technology in Atlanta, Georgia. He completed a residency in family medicine and a fellowship in obstetrics at the Franklin Square Hospital Center in Baltimore, Maryland. Rear Adm. Toedt is board certified in family medicine and is a fellow of the American Academy of Family Physicians.

Marvin Ventrell - (Ex Officio Member)
Marvin Ventrell became Executive Director of the National Association of Addiction Treatment Providers (NAATP) in 2015, continuing his 30-year career as a lawyer, association director, teacher, and addiction treatment executive. NAATP, founded in 1978, is a professional membership association of addiction treatment providers whose mission is to provide leadership, advocacy, training, and member support services that ensure the availability and highest quality of addiction treatment.

Mr. Ventrell’s career has been devoted to advocating for populations in need and building legal and health care system responses to meet those needs. In addition to serving in executive leadership roles in several national social welfare and justice agencies, he has authored two textbooks on law and social justice, numerous book chapters and professional articles on law, medicine, social services, behavioral health, and addiction treatment and recovery. He lectures at universities and agencies in the U.S. and abroad and has served as a consultant to the U.S. Department of Health and Human Services. He has received numerous distinctions including an American Bar Association National Advocacy Award, the National Council of Juvenile Court Judges Meritorious Service to the Children of America Award, the
University of Colorado School of Medicine Award for Career Contributions to the Worldwide Welfare of Children, and the Innovator Award from Ashley Treatment Centers given for impact in the field of recovery through innovation, commitment, and dynamic thinking.



No data present.



No data present.